Parental Drug Product

Dr. Claudia Müller

Claudia is currently Associate Director and Head of a Formulation Development Team within Lonza Drug Product Services at Basel with over 12 years’ industry experience that included large companies like Roche and Novartis. Her expertise covers large and small molecule parenteral drug product development including formulation and process development for early- to late-phase and commercial products, clinical manufacture, in-use compatibility studies, drug product process transfer to commercial manufacturing sites including process validation and regulatory submissions (IND/IMPD, BLAs, MAAs). She is author or co-author of several relevant publications and book chapters in the field. Claudia studied Pharmacy at The University of Jena, Germany and earned her Ph.D. in Pharmaceutical Technology from The University of Geneva, Switzerland.

Content by this expert

Recently published by Claudia

Whitepaper/Executive Summary

Dr. Claudia Müller

Recently published by Claudia

Q&A: The Key Enablers of Late-Phase Biologics Development and Launch

How Can You Ensure Successful Late-Phase Development And Launch Of Your Biologic Drug Product?

Key Enablers for Successful Late Phase Biologic Drug Product Development and Launch